Marinus Pharma (MRNS) Reports Q2 Loss of $0.46
Tweet
Share
E-mailGet Alerts MRNS Hot Sheet
Join SI Premium – FREE
Marinus Pharma (NASDAQ: MRNS) reported Q2 EPS of ($0.46), versus ($0.37) reported last year.
For earnings history and earnings-related data on Marinus Pharma (MRNS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- TD Cowen on Alaska Air (ALK): 'Can Alaska ReAccelerate?'
- Worthington Industries (WOR) Tops Q1 EPS by 7c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
